Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Clin Exp Nephrol ; 22(4): 773-781, 2018 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-29230587

RESUMEN

BACKGROUND: Arterial hypertrophy and interstitial fibrosis are important characteristics in kidneys of angiotensinogen-knockout (Atg -/-) mice. In these mice, which exhibit polyuria and hypotension, sympathetic nerve signaling is estimated to be compensatorily hyperactive. Furthermore, transforming growth factor (TGF)-ß1 is overexpressed in mice kidneys. To determine whether sympathetic nerve signaling and TGF-ß1 exacerbate arterial hypertrophy and interstitial fibrosis, intervention studies of such signaling are required. METHODS: We performed renal denervation and administered the α2-adrenergic receptor (AR) antagonist, atipamezole, to Atg -/- mice. A renin inhibitor, aliskiren, which was preliminarily confirmed to reduce TGF-ß1 gene expression in kidneys of the mice, was additionally administered to assess the effect on the arterial hypertrophy and interstitial fibrosis. RESULTS: Norepinephrine content in kidneys of Atg -/- mice was three times higher than in kidneys of wild-type mice. Interventions by renal denervation and atipamezole resulted in amelioration of the histological findings. Overexpression of TGF-ß1 gene in kidneys of Atg -/- mice was altered in a manner linked to the histological findings. Surprisingly, aliskiren reduced α2-AR gene expression, interstitial fibrosis, and arterial hypertrophy in kidneys of Atg -/- mice, which lack renin substrate. CONCLUSIONS: Alpha2-AR signaling is one of the causes of persistent renal arterial hypertrophy in Atg -/- mice. Aliskiren also angiotensinogen-independently reduces the extent of renal arterial hypertrophy, partly thorough downregulation of α2-ARs. Although renal arterial hypertrophy in Atg -/- mice appears to be of multifactorial origin, TGF-ß1 may play a key role in the persistence of such hypertrophy.


Asunto(s)
Antagonistas de Receptores Adrenérgicos alfa 2/farmacología , Amidas/farmacología , Fumaratos/farmacología , Arteria Renal/patología , Angiotensinógeno/genética , Animales , Fibrosis , Hipertrofia , Japón , Riñón , Ratones , Ratones Endogámicos ICR , Ratones Noqueados , Renina , Tokio , Factor de Crecimiento Transformador beta1
2.
J Anesth ; 28(4): 610-2, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24310852

RESUMEN

We encountered a 2-year-old child with life-threatening hypercapnia, with a PaCO(2) of 238 mm Hg and severe respiratory and metabolic acidosis, due to status asthmaticus that was refractory to steroid and bronchodilator therapy. Suspecting ventilatory failure and excessive ventilation-induced obstructive shock, we started respiratory physiotherapy in synchrony with her respiration, to facilitate exhalation from her over-inflated lungs. Isoflurane inhalation was commenced in preparation for extracorporeal circulation, to reduce the hypercapnia. The combination of respiratory physiotherapy and isoflurane inhalation resulted in a rapid decrease in ventilatory resistance and PaCO(2) levels within a few minutes, with recovery of consciousness within 60 min. Isoflurane inhalation was gradually discontinued and steroid and aminophylline therapy were commenced. The patient recovered completely without any recurrence of her bronchospasm and without any residual neurological deficits. In our patient with a severe asthmatic attack, decreased exhalation secondary to asthma and overventilation during artificial ventilation resulted in overinflation of the lungs, which in turn led to cerebral edema and obstructive cardiac failure. The favorable outcome in this case was due to the short duration of hypercapnia. Hence, we conclude that the duration of hypercapnia is an important determinant of the morbidity and mortality of status asthmaticus-induced severe hypercapnia.


Asunto(s)
Anestésicos por Inhalación/uso terapéutico , Hipercapnia/terapia , Isoflurano/uso terapéutico , Estado Asmático/terapia , Asma/complicaciones , Asma/terapia , Dióxido de Carbono/sangre , Coma/terapia , Femenino , Humanos , Hipercapnia/etiología , Lactante , Estado Asmático/complicaciones , Resultado del Tratamiento
3.
Appl Environ Microbiol ; 79(5): 1619-28, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23275503

RESUMEN

Deoxynivalenol (DON) is a natural toxin of fungi that cause Fusarium head blight disease of wheat and other small-grain cereals. DON accumulates in infected grains and promotes the spread of the infection on wheat, posing serious problems to grain production. The elucidation of DON-catabolic genes and enzymes in DON-degrading microbes will provide new approaches to decrease DON contamination. Here, we report a cytochrome P450 system capable of catabolizing DON in Sphingomonas sp. strain KSM1, a DON-utilizing bacterium newly isolated from lake water. The P450 gene ddnA was cloned through an activity-based screening of a KSM1 genomic library. The genes of its redox partner candidates (flavin adenine dinucleotide [FAD]-dependent ferredoxin reductase and mitochondrial-type [2Fe-2S] ferredoxin) were not found adjacent to ddnA; the redox partner candidates were further cloned separately based on conserved motifs. The DON-catabolic activity was reconstituted in vitro in an electron transfer chain comprising the three enzymes and NADH, with a catalytic efficiency (k(cat)/K(m)) of 6.4 mM(-1) s(-1). The reaction product was identified as 16-hydroxy-deoxynivalenol. A bioassay using wheat seedlings revealed that the hydroxylation dramatically reduced the toxicity of DON to wheat. The enzyme system showed similar catalytic efficiencies toward nivalenol and 3-acetyl deoxynivalenol, toxins that frequently cooccur with DON. These findings identify an enzyme system that catabolizes DON, leading to reduced phytotoxicity to wheat.


Asunto(s)
Proteínas Bacterianas/metabolismo , Sistema Enzimático del Citocromo P-450/metabolismo , Sphingomonas/enzimología , Tricotecenos/metabolismo , Proteínas Bacterianas/genética , Clonación Molecular , Coenzimas/metabolismo , Sistema Enzimático del Citocromo P-450/genética , ADN Bacteriano/química , ADN Bacteriano/genética , Cinética , Datos de Secuencia Molecular , NAD/metabolismo , Oxidación-Reducción , Análisis de Secuencia de ADN , Sphingomonas/aislamiento & purificación , Microbiología del Agua
5.
Neurol Med Chir (Tokyo) ; 63(5): 213-219, 2023 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-36754418

RESUMEN

We describe a three-step, simple binostril approach to endoscopic endonasal transsphenoidal surgery in cases of sellar/parasellar lesions. In the first step, the mucosa of the lower third of the ethmoid bulla on the outside was coagulated with monopolar microdissection needle and opened to create space on the outside of the middle turbinate. The middle turbinate was moved outward using this space, and the natural ostium of the sphenoid sinus could be confirmed easily. In the second step, a less than 10 mm incision was made from the right natural ostium of the sphenoid sinus to the right nasal septal mucosa. The anterior wall of the sphenoid sinus was removed to free the sphenoid sinus. In the third step, the instrument was inserted through the left nostril using a hole connected to the natural ostium of the sphenoid sinus to reach the sellar floor via both nostrils. It took longer for the trainee than for the instructor to reach the sellar floor in the first four cases. However, there was no significant difference in the approach time after the fifth case. Approach-related postoperative complications were observed in 52 cases of sellar/parasellar lesions performed. This approach was considered to provide sufficient space and was simple and less burdensome to the patient.


Asunto(s)
Endoscopía , Neoplasias Hipofisarias , Humanos , Endoscopía/efectos adversos , Cavidad Nasal/patología , Cavidad Nasal/cirugía , Cornetes Nasales , Seno Esfenoidal/cirugía , Seno Esfenoidal/patología , Complicaciones Posoperatorias/etiología , Neoplasias Hipofisarias/cirugía , Neoplasias Hipofisarias/patología
6.
Surg Neurol Int ; 13: 30, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35242396

RESUMEN

BACKGROUND: The use of the exoscope has been increasing in the field of neurosurgery, as it can set the visual axis freely, enabling the surgeon to operate in a comfortable posture. Although endoscope-assisted surgery for compensation of insufficient surgical field is useful under the microscope, we report that using an endoscope in exoscopic surgery is safer and more useful. METHODS: The exoscope used was ORBEYE. All surgical procedures were performed exoscopically from the beginning of the surgery. When endoscopic observation was required during the operation, the endoscope was inserted under observation by an exoscope. The exoscopic screen was 4K-3D and endoscopic screen was 4K-2D, the operation was performed while observing both screens at the same time. The endoscope was held manually or by a mechanical holder. RESULTS: Twenty-two cases, including 14 requiring microvascular decompression (MVD) and eight requiring tumor removal, were performed by endoscopic-assisted exoscopic surgery. The endoscope could be inserted safely because its relationship with the surrounding structure could be observed under the exoscope, and the operator could observe both screens without moving the head. Fourteen of 22 patients required additional endoscopic treatment. Satisfactory two-handed operation was performed in 13 cases. Symptomatology disappeared in all cases of MVD, and sufficient tumor resection was achieved. CONCLUSION: Exoscopic surgery provides excellent surgical view that is not inferior to conventional microsurgery. As a large space can be secured between the scope and the surgical field, it is safer and easier to manipulate the endoscope under the exoscope.

7.
Prostate ; 71(9): 964-75, 2011 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-21541973

RESUMEN

BACKGROUND: Although the local renin-angiotensin system (RAS) of the prostate gland is related to cell proliferation and angiogenesis, the detailed mechanism remains unclear. We examined the effects of the angiotensin II type 1 receptor (AT1R) on androgen receptor (AR) expression in prostate cancer cells. METHODS: AR modulation by AT1R was examined by Western blot analysis, luciferase assay, and Immunocytochemical staining. The influence of AR expression by angiotensin II (Ang-II) and AT1R inhibition using siRNA was determined. Furthermore, using angiotensinogen or AT1R knockout (KO) mice, we performed quantitative real-time PCR to investigate the expression of AR. RESULTS: Ang-II induced cell proliferation with enhancement of AR, prostate specific antigen (PSA), NF-κB, and c-myc, and the activity of AR and PSA promoter. Cell proliferation of LNCaP transfected with AT1R siRNA was decreased by 75% at 7 days by inhibition of AR, PSA, NF-κB, and c-myc. Immunocytochemical staining confirmed the suppression of AR translocation into the nucleus in AT1R siRNA cells. AT1R KO mice showed a decrease in AR expression in the prostate gland. We also found that the expression level of AT1R could modulate the transcriptional level of AR by affecting NF-κB and c-myc expression. CONCLUSIONS: Knocking down of the AT1R protein resulted in significant inhibition of cell growth, associated with a marked decrease of AR protein. These results indicate that inhibition of AT1R has the potential to influence AR expression in prostate cells, and is anticipated to contribute to the development of novel therapeutic agents for prostate cancer.


Asunto(s)
Neoplasias de la Próstata/metabolismo , Receptor de Angiotensina Tipo 1/metabolismo , Receptores Androgénicos/biosíntesis , Angiotensina II/metabolismo , Animales , Western Blotting , Línea Celular Tumoral , Proliferación Celular , Regulación Neoplásica de la Expresión Génica , Inmunohistoquímica , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos ICR , Ratones Noqueados , FN-kappa B/metabolismo , Antígeno Prostático Específico/metabolismo , Neoplasias de la Próstata/genética , Proteínas Proto-Oncogénicas c-myc/metabolismo , ARN/química , ARN/genética , ARN Interferente Pequeño/farmacología , Receptores Androgénicos/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
8.
J Anesth ; 25(6): 935-8, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21904782

RESUMEN

We report a case of laxatives induced severe hypermagnesemia complicated with cardiopulmonary arrest. A 55-year-old woman, with nephritic syndrome and anorexia nervosa, was later transported to our emergency room (ER) because of oliguria and consciousness disturbance. During transfer to the intensive care unit from the ER, cardiopulmonary arrest suddenly occurred. Cardiopulmonary resuscitation was immediately performed, and spontaneous circulation was restored after 3 min. Thereafter, administration of dopamine, norepinephrine, and epinephrine was required to maintain systolic blood pressure at 80 mmHg. Arterial blood gas analysis showed severe metabolic alkalosis, and blood biochemical tests revealed hypermagnesemia (serum magnesium concentration, 18.5 mg/dl) and renal dysfunction. Continuous infusion of diuretics followed by massive hydration and continuous hemodiafiltration (CHDF) was started. Five days after starting CHDF, magnesium concentration was almost normalized and administration of catecholamine was stopped. It was thought that progression of renal dysfunction that occurred in the patient taking a magnesium product for chronic constipation caused reduction in magnesium excretion ability, resulting in hypermagnesemia-induced cardiopulmonary arrest. To avoid a rebound phenomenon following magnesium flux from cells, continuous blood purification seems to be an effective treatment for symptomatic hypermagnesemia.


Asunto(s)
Anorexia Nerviosa/sangre , Paro Cardíaco/inducido químicamente , Paro Cardíaco/etiología , Fallo Renal Crónico/sangre , Laxativos/efectos adversos , Magnesio/sangre , Anorexia Nerviosa/fisiopatología , Estreñimiento/tratamiento farmacológico , Femenino , Paro Cardíaco/sangre , Humanos , Fallo Renal Crónico/fisiopatología , Persona de Mediana Edad
9.
Am J Physiol Renal Physiol ; 299(4): F720-31, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20685825

RESUMEN

The intrarenal renin-angiotensin system plays a crucial role in the regulation of renal circulation and sodium reabsorption through the activation of vascular, glomerular, and tubular angiotensin II type 1 (AT(1)) receptor signaling. We previously cloned a molecule that specifically interacted with the murine AT(1) receptor to inhibit AT(1) receptor signaling, which we named ATRAP (for AT(1) receptor-associated protein). Since murine ATRAP was shown to be highly expressed in the kidney, in the present study we investigated expression and distribution of human ATRAP in normal kidney and renal biopsy specimens from patients with IgA nephropathy. In the normal human kidney, both ATRAP mRNA and protein were widely and abundantly distributed along the renal tubules from Bowman's capsule to the medullary collecting ducts. In all renal tubular epithelial cells, the ATRAP protein colocalized with the AT(1) receptor. In renal biopsy specimens with IgA nephropathy, a significant positive correlation between ATRAP and AT(1) receptor gene expression was observed. There was also a positive relationship between tubulointerstitial ATRAP expression and the estimated glomerular filtration rate in patients with IgA nephropathy. Furthermore, we examined the function of the tubular AT(1) receptor using an immortalized cell line of mouse distal convoluted tubule cells (mDCT) and found that overexpression of ATRAP by adenoviral gene transfer suppressed the angiotensin II-mediated increases in transforming growth factor-ß production in mDCT cells. These findings suggest that ATRAP might play a role in balancing the renal renin-angiotensin system synergistically with the AT(1) receptor by counterregulatory effects in IgA nephropathy and propose an antagonistic effect of tubular ATRAP on AT(1) receptor signaling.


Asunto(s)
Proteínas Adaptadoras Transductoras de Señales/metabolismo , Glomerulonefritis por IGA/metabolismo , Riñón/metabolismo , Receptor de Angiotensina Tipo 1/metabolismo , Animales , Biopsia , Línea Celular , Estudios Transversales , Glomerulonefritis por IGA/patología , Humanos , Riñón/patología , Túbulos Renales Distales/metabolismo , Masculino , Ratones , Modelos Animales , Miocardio/citología , Miocardio/metabolismo , ARN Mensajero/metabolismo , Ratas , Sistema Renina-Angiotensina/fisiología
10.
Data Brief ; 30: 105568, 2020 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-32368595

RESUMEN

The structural investigation of synthesized compounds can be carried out by various spectroscopic techniques. It is an important prospect in order to elucidate the structure of the desired products before being further utilized. The preparation of new p-nitro stilbene Schiff base derivatives as an electrochemical DNA potential spacer was synthesized using (E)-4-(4-nitrostyryl)aniline from Heck reaction with aldehydes in ethanolic solution. The data presented here in this article contains FTIR, UV-Vis and 1H and 13C NMR of (E)-4-(4-nitrostyryl)aniline and nitrostyryl aniline derivatives.

11.
Nephron Exp Nephrol ; 111(1): e20-30, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19052474

RESUMEN

BACKGROUNDS/AIMS: It has been reported that urinary oxidative stress markers are higher in diabetic patients with proteinuria. We performed the present study to elucidate the relationship between urinary excretion of oxidative stress markers, albumin excretion, and histological changes, and to confirm the potential utility of oxidative stress markers for clinical treatment. METHODS: Diabetic db/db mice or nondiabetic db/m mice were administered candesartan (10 mg/kg/day) or hydralazine (50 mg/kg/day) for 18 weeks. RESULTS: Thirty-week-old male db/db mice treated with control vehicle revealed elevated urinary excretion and immunohistological levels of 8-hydroxydeoxyguanosine in glomeruli when compared to db/m mice. Treatment with candesartan, but not hydralazine, reduced these values to levels in db/m mice. Increased mesangial expansion, urinary excretion of albumin and 8-isoprostane, and glomerular immunohistological levels of nitrotyrosine in db/db mice were also decreased markedly by candesartan but not hydralazine. Interestingly, correlations between levels of albumin and oxidative stress markers in urine were very high, even when groups undergoing long-term (44 weeks) treatment were included (correlation coefficient 0.767 with respect to 8-hydroxydeoxyguanosine, 0.888 with respect to 8-isoprostane). CONCLUSION: It is anticipated that urinary concentrations of oxidative stress markers will be direct barometers of glomerulus-derived oxidative stress and glomerular injury in diabetic nephropathy.


Asunto(s)
Bloqueadores del Receptor Tipo 1 de Angiotensina II/uso terapéutico , Bencimidazoles/uso terapéutico , Desoxiguanosina/análogos & derivados , Nefropatías Diabéticas/tratamiento farmacológico , Nefropatías Diabéticas/orina , Dinoprost/análogos & derivados , Tetrazoles/uso terapéutico , Tirosina/análogos & derivados , 8-Hidroxi-2'-Desoxicoguanosina , Albuminuria/orina , Bloqueadores del Receptor Tipo 1 de Angiotensina II/farmacocinética , Animales , Antihipertensivos/uso terapéutico , Bencimidazoles/farmacocinética , Biomarcadores/orina , Compuestos de Bifenilo , Desoxiguanosina/orina , Diabetes Mellitus/fisiopatología , Diabetes Mellitus/orina , Nefropatías Diabéticas/fisiopatología , Dinoprost/orina , Modelos Animales de Enfermedad , Hidralazina/uso terapéutico , Glomérulos Renales/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Estrés Oxidativo/fisiología , Tetrazoles/farmacocinética , Resultado del Tratamiento , Tirosina/orina
12.
Bone Marrow Transplant ; 54(9): 1399-1405, 2019 09.
Artículo en Inglés | MEDLINE | ID: mdl-30664725

RESUMEN

A dose-intensified multi-agent chemotherapy regimen called VCAP-AMP-VECP was investigated in Japan as front-line therapy for patients with adult T-cell leukemia-lymphoma (ATL). Although a prospective randomized controlled study showed that VCAP-AMP-VECP was superior to CHOP, the trial was rather small and no subsequent studies confirmed the benefit of VCAP-AMP-VECP over CHOP. We conducted a retrospective analysis of transplant-eligible patients with ATL who received only VCAP-AMP-VECP or CHOP, incorporating inverse probability of treatment weighting (IPTW) using propensity scoring. Overall, 947 and 513 patients were treated with VCAP-AMP-VECP and CHOP, respectively. The median follow-up of surviving patients was 1006 days. The crude probabilities of 2-year overall survival (OS) for patients in the VCAP-AMP-VECP and CHOP groups were 31.2% and 24.6%, respectively (P < 0.001). Stratified by risk group according to the modified ATL-prognostic index score at diagnosis, the crude probabilities of 2-year OS in the VCAP-AMP-VECP and CHOP groups were 39.8 and 45.0% in the low-risk group (P = 0.69), 32.2 and 21.6% in the intermediate-risk group (P < 0.001), and 17.2 and 6.2% in the high-risk group (P = 0.005). Our current analysis suggests that VCAP-AMP-VECP regimen is a preferable front-line therapy in patients with aggressive ATL in intermediate- and high-risk groups.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Quimioterapia de Inducción , Leucemia-Linfoma de Células T del Adulto/tratamiento farmacológico , Leucemia-Linfoma de Células T del Adulto/mortalidad , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Supervivencia sin Enfermedad , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Puntaje de Propensión , Factores de Riesgo , Tasa de Supervivencia
13.
Arterioscler Thromb Vasc Biol ; 26(6): 1267-72, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16556853

RESUMEN

OBJECTIVE: Physiological roles of apelin and its specific receptor APJ signaling were investigated in vascular smooth muscle cells (VSMCs). The present study determined whether apelin activates myosin light chain (MLC), a major regulatory event in initiating smooth muscle contraction. METHODS AND RESULTS: To assess MLC activation, we performed Western blot and immunohistochemical studies using an antibody against the phospho-MLC. In VSMCs, apelin induces the phosphorylation of MLC in a concentration-dependent manner with a peak at 2 minutes. Pretreatment of VSMCs with pertussis toxin abolishes the apelin-induced phosphorylation of MLC. Inhibition of protein kinase C (PKC) with GF-109203X markedly attenuated the apelin-induced MLC phosphorylation. In addition, methylisobutyl amiloride, a specific inhibitor of the Na+/H+ exchanger (NHE), and KB-R7943, a potent inhibitor for the reverse mode of the Na+/Ca2+ exchanger (NCX), significantly suppressed the action of apelin. In wild-type mice, apelin phosphorylates MLC in vascular tissue, whereas it had no response in APJ-deficient mice by Western blot and immunohistochemistry. Apelin-induced phosphorylation of MLC was accompanied with myosin phosphatase target subunit phosphorylation. CONCLUSIONS: These results provide the first evidence to our knowledge for apelin-mediated MLC phosphorylation in vitro and in vivo, which is a potential mechanism of apelin-mediated vasoconstriction.


Asunto(s)
Proteínas Portadoras/fisiología , Músculo Liso Vascular/metabolismo , Miocitos del Músculo Liso/metabolismo , Cadenas Ligeras de Miosina/metabolismo , Adipoquinas , Animales , Aorta Torácica , Apelina , Receptores de Apelina , Células Cultivadas , Inhibidores Enzimáticos , Estrenos/farmacología , Proteínas de Unión al GTP/antagonistas & inhibidores , Técnicas In Vitro , Indoles/farmacología , Péptidos y Proteínas de Señalización Intercelular , Intercambio Iónico , Masculino , Maleimidas/farmacología , Toxina del Pertussis/farmacología , Inhibidores de Fosfodiesterasa/farmacología , Fosforilación , Proteína Quinasa C/antagonistas & inhibidores , Pirrolidinonas/farmacología , Ratas , Ratas Wistar , Receptores Acoplados a Proteínas G/metabolismo
14.
J Vet Med Sci ; 66(6): 729-33, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15240953

RESUMEN

Automated ribotyping classified 70 Erysipelothrix species strains, previously classified into 14 RAPD patterns and into 63 PFGE patterns, into 27 ribogroups. Twenty-three strains of the 70 analyzed and classified into 13 ribogroups were previously classified into six ribotypes by the traditional ribotyping method. Moreover, automated ribotyping differentiated seven strains that were not differentiated by PFGE. Therefore, automated ribotyping was more sensitive than RAPD and traditional ribotyping, and it might be a useful method for a rapid screening in epidemiological study of strains of this genus, and more accurate results can be obtained when this method is used together with PFGE.


Asunto(s)
Erysipelothrix/genética , Ribotipificación/veterinaria , Automatización/métodos , ADN Bacteriano/análisis , Electroforesis en Gel de Campo Pulsado/veterinaria , ARN Ribosómico 16S/genética , Técnica del ADN Polimorfo Amplificado Aleatorio/veterinaria , Ribotipificación/métodos , Sensibilidad y Especificidad
15.
Masui ; 52(12): 1320-2, 2003 Dec.
Artículo en Japonés | MEDLINE | ID: mdl-14733084

RESUMEN

A 68-year-old man with reactive thrombocytemia (platelet count: 97.2 x 10(4).mm-3) underwent liver subsegmentectomy for hepatocellular carcinoma. Thoracic epidural combined with general anesthesia was carried out for the surgery. Platelet aggregability was monitored during the operation. At the beginning of the operation, platelet aggregability to aggregating factor ADP showed an abnormal pattern without dose dependency. In spite of continuous administration of gabexate mesilate for inhibition of thrombosis, the patient developed hypercapnia with low end tidal CO2 pressure (PETCO2) and hypoxia, suggesting pulmonary embolism. PETCO2 and SPO2 recovered soon after heparin administration. The patient recovered without any neurologic complications. This case demonstrated that hyperaggregability is possible in patients with thrombocytemia and suggests that monitoring of platelet function in patients with thrombocytemia is difficult.


Asunto(s)
Hepatectomía , Complicaciones Intraoperatorias/etiología , Embolia Pulmonar/etiología , Trombocitosis/complicaciones , Anciano , Anestesia Epidural , Anestesia General , Carcinoma Hepatocelular/complicaciones , Carcinoma Hepatocelular/cirugía , Humanos , Complicaciones Intraoperatorias/diagnóstico , Neoplasias Hepáticas/complicaciones , Neoplasias Hepáticas/cirugía , Masculino , Monitoreo Intraoperatorio , Agregación Plaquetaria , Embolia Pulmonar/diagnóstico , Trombocitosis/sangre
16.
Masui ; 53(7): 803-5, 2004 Jul.
Artículo en Japonés | MEDLINE | ID: mdl-15298252

RESUMEN

A 55-year-old man was admitted to our hospital for treatment of renal cell carcinoma. Preoperative MRI showed infradiaphragmatic extension of the tumor thrombus. However, intraoperative transesophageal echocardiography (TEE) revealed intracardiac extension of the thrombus. Therefore, the tumor thrombus was extirpated under cardiopulmonary bypass. The patient recovered without any complications. Intraoperative TEE monitoring is useful not only for the evaluation of cardiac functions but also for intraoperative diagnosis of a tumor thrombus during the operation for renal cell carcinoma.


Asunto(s)
Carcinoma de Células Renales/cirugía , Ecocardiografía Transesofágica , Neoplasias Cardíacas/diagnóstico por imagen , Neoplasias Renales/cirugía , Monitoreo Intraoperatorio , Células Neoplásicas Circulantes , Puente Cardiopulmonar , Atrios Cardíacos , Neoplasias Cardíacas/cirugía , Humanos , Masculino , Persona de Mediana Edad , Resultado del Tratamiento
17.
Int J Hematol ; 97(1): 98-102, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23243003

RESUMEN

Mature T cell lymphoma has been noted for poor prognosis when compared with B cell lymphoma, even in the pre-rituximab era. To confirm this difference, a retrospective cohort study was conducted. One hundred-and nineteen patients with mature T cell lymphoma and 568 patients with diffuse large B cell lymphoma (DLBCL) who did not receive rituximab as first induction were studied. Overall survival (OS) was worse for patients with international prognostic index (IPI) scores indicating low-risk mature T cell lymphoma than for those with DLBCL (3-year OS 87 % vs. 58 %, P = 0.001), but not in other risk groups. Prognosis of mature T cell lymphoma was significantly poorer in the IPI low-risk group, as compared with DLBCL.


Asunto(s)
Linfoma de Células B Grandes Difuso/mortalidad , Linfoma de Células B Grandes Difuso/patología , Linfoma de Células T/mortalidad , Linfoma de Células T/patología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Femenino , Humanos , Linfoma de Células B Grandes Difuso/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Pronóstico , Estudios Retrospectivos , Adulto Joven
18.
Hypertension ; 59(4): 854-60, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22311909

RESUMEN

We reported previously that ATP2B1 was one of the genes for hypertension receptivity in a large-scale Japanese population, which has been replicated recently in Europeans and Koreans. ATP2B1 encodes the plasma membrane calcium ATPase isoform 1, which plays a critical role in intracellular calcium homeostasis. In addition, it is suggested that ATP2B1 plays a major role in vascular smooth muscle contraction. Because the ATP2B1 knockout (KO) mouse is embryo-lethal, we generated mice with vascular smooth muscle cell-specific KO of ATP2B1 using the Cre-loxP system to clarify the relationship between ATP2B1 and hypertension. The KO mice expressed significantly lower levels of ATP2B1 mRNA and protein in the aorta compared with control mice. KO mice showed significantly higher systolic blood pressure as measured by tail-cuff method and radiotelemetric method. Similar to ATP2B1, the expression of the Na(+)-Ca(2+) exchanger isoform 1 mRNA was decreased in vascular smooth muscle cells of KO mice. However, ATP2B4 expression was increased in KO mice. The cultured vascular smooth muscle cells of KO mice showed increased intracellular calcium concentration not only in basal condition but also in phenylephrine-stimulated condition. Furthermore, phenylephrine-induced vasoconstriction was significantly increased in vascular rings of the femoral artery of KO mice. These results suggest that ATP2B1 plays important roles in the regulation of blood pressure through alteration of calcium handling and vasoconstriction in vascular smooth muscle cells.


Asunto(s)
Presión Sanguínea/fisiología , Hipertensión/genética , Hipertensión/fisiopatología , Músculo Liso Vascular/fisiopatología , ATPasas Transportadoras de Calcio de la Membrana Plasmática/genética , Animales , Calcio/metabolismo , Células Cultivadas , Modelos Animales de Enfermedad , Arteria Femoral/efectos de los fármacos , Arteria Femoral/fisiología , Eliminación de Gen , Homeostasis/fisiología , Ratones , Ratones Noqueados , Músculo Liso Vascular/efectos de los fármacos , Músculo Liso Vascular/patología , Fenilefrina/farmacología , ATPasas Transportadoras de Calcio de la Membrana Plasmática/deficiencia , Vasoconstricción/efectos de los fármacos , Vasoconstricción/fisiología
20.
Clin Exp Nephrol ; 12(3): 224-7, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18224274

RESUMEN

A 65-year-old woman with a 48-year history of Behçet's disease associated with nephrotic syndrome is described. Immunofluorescence study revealed IgA nephropathy. Following treatment with an angiotensin II type-I receptor-blocker, an anti-platelet drug, and an HMG-CoA reductase inhibitor, accompanied by dietary restrictions of protein and sodium, proteinuria was markedly decreased. This report describes our experience with a rare entity of Behçet's disease complicated by nephrotic syndrome due to IgA nephropathy. Routine urine examination and renal biopsy are needed for the detection and diagnosis of renal problems with Behçet's disease.


Asunto(s)
Síndrome de Behçet/complicaciones , Síndrome de Behçet/diagnóstico , Glomerulonefritis por IGA/complicaciones , Síndrome Nefrótico/complicaciones , Síndrome Nefrótico/diagnóstico , Anciano , Bloqueadores del Receptor Tipo 1 de Angiotensina II/uso terapéutico , Atorvastatina , Síndrome de Behçet/tratamiento farmacológico , Bencimidazoles/uso terapéutico , Compuestos de Bifenilo/uso terapéutico , Dilazep/uso terapéutico , Quimioterapia Combinada , Femenino , Ácidos Heptanoicos/uso terapéutico , Humanos , Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico , Síndrome Nefrótico/etiología , Pirroles/uso terapéutico , Tetrazoles/uso terapéutico , Vasodilatadores/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA